CRNX · Categories · Coverage
CRNX - Analyst coverage initiated
Crinetics Pharmaceuticals Inc. (CRNX) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for CRNX
- UBS initiated coverage on Crinetics Pharmaceuticals with a new price targetUBS initiated coverage of Crinetics Pharmaceuticals with a rating of Buy and set a new price target of $55.00
- Goldman initiated coverage on Crinetics Pharmaceuticals with a new price targetGoldman initiated coverage of Crinetics Pharmaceuticals with a rating of Neutral and set a new price target of $36.00
- Stifel initiated coverage on Crinetics Pharmaceuticals with a new price targetStifel initiated coverage of Crinetics Pharmaceuticals with a rating of Buy and set a new price target of $60.00
- TD Cowen initiated coverage on Crinetics PharmaceuticalsTD Cowen initiated coverage of Crinetics Pharmaceuticals with a rating of Buy
- Wolfe Research initiated coverage on Crinetics PharmaceuticalsWolfe Research initiated coverage of Crinetics Pharmaceuticals with a rating of Peer Perform
- Citigroup initiated coverage on Crinetics Pharmaceuticals with a new price targetCitigroup initiated coverage of Crinetics Pharmaceuticals with a rating of Buy and set a new price target of $68.00
- Morgan Stanley initiated coverage on Crinetics Pharmaceuticals with a new price targetMorgan Stanley initiated coverage of Crinetics Pharmaceuticals with a rating of Overweight and set a new price target of $50.00
- Jefferies initiated coverage on Crinetics Pharmaceuticals with a new price targetJefferies initiated coverage of Crinetics Pharmaceuticals with a rating of Hold and set a new price target of $35.00
- Oppenheimer initiated coverage on Crinetics Pharmaceuticals with a new price targetOppenheimer initiated coverage of Crinetics Pharmaceuticals with a rating of Outperform and set a new price target of $40.00
- Piper Sandler initiated coverage on Crinetics Pharmaceuticals with a new price targetPiper Sandler initiated coverage of Crinetics Pharmaceuticals with a rating of Overweight and set a new price target of $56.00
- Robert W. Baird initiated coverage on Crinetics Pharmaceuticals with a new price targetRobert W. Baird initiated coverage of Crinetics Pharmaceuticals with a rating of Outperform and set a new price target of $48.00
- JMP Securities initiated coverage on Crinetics Pharmaceuticals with a new price targetJMP Securities initiated coverage of Crinetics Pharmaceuticals with a rating of Mkt Outperform and set a new price target of $43.00
- Evercore ISI initiated coverage on Crinetics Pharmaceuticals with a new price targetEvercore ISI initiated coverage of Crinetics Pharmaceuticals with a rating of Outperform and set a new price target of $68.00
- JonesTrading initiated coverage on Crinetics Pharmaceuticals with a new price targetJonesTrading initiated coverage of Crinetics Pharmaceuticals with a rating of Buy and set a new price target of $42.00